دورية أكاديمية
Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial
| العنوان: | Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial |
|---|---|
| المؤلفون: | Blauvelt, Andrew, Langley, Richard G., Lacour, Jean-Philippe, Toth, Darryl, Laquer, Vivian, Beissert, Stefan, Wollenberg, Andreas, Herranz, Pedro, Pink, Andrew E., Peris, Ketty, Fangel, Stine, Gjerum, Le, Corriveau, Joshua, Saeki, Hidehisa, Warren, Richard B., Simpson, Eric, Reich, Kristian |
| المساهمون: | Leo Pharma Research Foundation |
| المصدر: | Journal of the American Academy of Dermatology ; volume 87, issue 4, page 815-824 ; ISSN 0190-9622 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.jaad.2022.07.019 |
| الإتاحة: | https://doi.org/10.1016/j.jaad.2022.07.019Test https://api.elsevier.com/content/article/PII:S0190962222023453?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0190962222023453?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by/4.0Test/ |
| رقم الانضمام: | edsbas.AD55E5CF |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.jaad.2022.07.019 |
|---|